Orthofix International N.V. (NASDAQ:OFIX) Expected to Post Earnings of $0.41 Per Share
Equities research analysts expect that Orthofix International N.V. (NASDAQ:OFIX) will post $0.41 earnings per share (EPS) for the current quarter, according to Zacks. Two analysts have issued estimates for Orthofix International N.V.’s earnings. The lowest EPS estimate is $0.36 and the highest is $0.45. Orthofix International N.V. reported earnings per share of $0.36 in the same quarter last year, which would suggest a positive year over year growth rate of 13.9%. The company is scheduled to announce its next earnings report on Monday, October 30th.
On average, analysts expect that Orthofix International N.V. will report full-year earnings of $1.40 per share for the current year, with EPS estimates ranging from $0.93 to $1.57. For the next financial year, analysts expect that the business will post earnings of $1.77 per share, with EPS estimates ranging from $1.64 to $1.95. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow Orthofix International N.V..
Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings data on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a return on equity of 9.96% and a net margin of 1.88%. The company had revenue of $108.90 million during the quarter, compared to analyst estimates of $102.94 million. During the same quarter in the previous year, the firm earned $0.41 earnings per share. Orthofix International N.V.’s revenue was up 4.6% on a year-over-year basis.
Several equities analysts have recently weighed in on OFIX shares. TheStreet raised shares of Orthofix International N.V. from a “c+” rating to a “b-” rating in a research report on Tuesday. BTIG Research started coverage on shares of Orthofix International N.V. in a research report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price objective on the stock. Langenberg & Company reissued a “buy” rating and issued a $53.25 price objective on shares of Orthofix International N.V. in a research report on Wednesday, June 14th. Ladenburg Thalmann Financial Services started coverage on shares of Orthofix International N.V. in a research report on Wednesday, June 14th. They issued a “buy” rating and a $53.25 price objective on the stock. Finally, SunTrust Banks, Inc. started coverage on shares of Orthofix International N.V. in a research report on Tuesday, May 23rd. They issued a “buy” rating and a $49.00 price objective on the stock. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $52.75.
Several institutional investors have recently added to or reduced their stakes in OFIX. State Street Corp increased its position in Orthofix International N.V. by 5.6% in the fourth quarter. State Street Corp now owns 364,267 shares of the medical device company’s stock valued at $13,179,000 after buying an additional 19,395 shares during the period. Norges Bank acquired a new position in Orthofix International N.V. during the fourth quarter valued at approximately $5,664,000. Teachers Advisors LLC increased its position in Orthofix International N.V. by 18.2% in the fourth quarter. Teachers Advisors LLC now owns 35,600 shares of the medical device company’s stock valued at $1,288,000 after buying an additional 5,489 shares during the period. Capstone Asset Management Co. acquired a new position in Orthofix International N.V. during the first quarter valued at approximately $204,000. Finally, Louisiana State Employees Retirement System acquired a new position in Orthofix International N.V. during the first quarter valued at approximately $278,000. Institutional investors and hedge funds own 99.68% of the company’s stock.
Shares of Orthofix International N.V. (OFIX) traded down 0.61% on Friday, hitting $46.95. The stock had a trading volume of 74,562 shares. Orthofix International N.V. has a 52 week low of $32.51 and a 52 week high of $49.60. The firm has a 50-day moving average price of $45.66 and a 200-day moving average price of $40.89. The stock has a market capitalization of $853.08 million, a P/E ratio of 109.95 and a beta of 0.25.
TRADEMARK VIOLATION WARNING: This report was first reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2017/08/11/orthofix-international-n-v-nasdaqofix-expected-to-post-earnings-of-0-41-per-share.html.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.